AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23766337 — intervention group
Group type: COMPARATOR
Intervention: Haemodialysis (HD)
Number of subjects: 0
Study 21332346 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose NCTD (0.05 mg/kg/day)
Number of subjects: 0
Study 21332346 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose NCTD (0.1 mg/kg/day)
Number of subjects: 0
Study 21332346 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 21332346 — intervention group
Group type: COMPARATOR
Intervention: Model group (DN rats without treatment)
Number of subjects: 0
Study 19732995 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to the reminiscence program)
Number of subjects: 90
Study 19732995 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 19732995 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control group (with weekly relaxation sessions)
Number of subjects: 90
Study 17237686 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-flap anastomosis (Group A)
Number of subjects: 63
Study 17237686 — intervention group
Group type: COMPARATOR
Intervention: Excision of the posterior flaps (Group B)
Number of subjects: 63
Study 15497493 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated estrogen (CE)/5 mg medroxyprogesterone acetate (MPA)
Number of subjects: 249
Study 15497493 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol/1 mg norethisterone acetate (NETA)
Number of subjects: 249
Study 15497493 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 249
Study 15497493 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol/NETA
Number of subjects: 249
Study 11521964 — intervention group
Group type: EXPERIMENTAL
Intervention: CLA supplementation (Tonalin capsules providing 3.9 g/d of CLA isomers)
Number of subjects: 17
Study 11521964 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil (sunflower) supplementation (6 daily capsules of 1 g each)
Number of subjects: 17
Study 11521964 — intervention group
Group type: EXPERIMENTAL
Intervention: CLA supplementation
Number of subjects: 17
Study 9469324 — intervention group
Group type: EXPERIMENTAL
Intervention: FU24h/LV
Number of subjects: 236
Study 9469324 — intervention group
Group type: COMPARATOR
Intervention: FU24h/IFN
Number of subjects: 236
Study 9469324 — intervention group
Group type: EXPERIMENTAL
Intervention: FU24h/LV/IFN
Number of subjects: 236
Study 7921857 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 60 mg
Number of subjects: 200
Study 7921857 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 40 mg
Number of subjects: 200
Study 7921857 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 20 mg
Number of subjects: 200
Study 7921857 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control Group A)
Number of subjects: 200
Study 3377947 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural diamorphine 5 mg in saline 10 ml with adrenaline 1 in 200,000
Number of subjects: 54
Study 3377947 — intervention group
Group type: COMPARATOR
Intervention: Extradural diamorphine 5 mg in saline 10 ml without adrenaline (saline group)
Number of subjects: 54
Study 5057006 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1 gram per day)
Number of subjects: 0
Study 5057006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31821698 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) intervention
Number of subjects: 37
Study 31297513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment using a tablet
Number of subjects: 67
Study 31297513 — intervention group
Group type: COMPARATOR
Intervention: Standard assessment by a research assistant (RA)
Number of subjects: 67
Study 31297513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment using a tablet (for patients aged ≥85)
Number of subjects: 67
Study 31297513 — intervention group
Group type: COMPARATOR
Intervention: Standard assessment by a research assistant (RA) (for caregivers)
Number of subjects: 67
Study 31297513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment using a tablet (for caregivers)
Number of subjects: 67
Study 29564034 — intervention group
Group type: EXPERIMENTAL
Intervention: Risky sexual behavior assessment among sexually active students
Number of subjects: 627
Study 29564034 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable logistic regression analysis
Number of subjects: 627
Study 26252290 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study 26252290 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30
Study 26252290 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane and Propofol
Number of subjects: 30
Study 23793776 — intervention group
Group type: EXPERIMENTAL
Intervention: HAP imaging with 80 kVp using a 320-detector-rows ADCT scanner
Number of subjects: 128
Study 23793776 — intervention group
Group type: COMPARATOR
Intervention: Routine HAP imaging with 120 kVp using 64-slice helical acquisition
Number of subjects: 128
Study 23793776 — intervention group
Group type: EXPERIMENTAL
Intervention: HAP imaging with 80 kVp
Number of subjects: 128
Study 21534836 — intervention group
Group type: COMPARATOR
Intervention: Multicomponent environmental intervention including employee advisory committees, point‐of‐decision prompts, walking paths, cafeteria/vending changes, and educational materials.
Number of subjects: 8
Study 21534836 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 8
Study 19559166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension self-management intervention delivered by a nurse over the telephone
Number of subjects: 528
Study 19559166 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 528
Study 16445258 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid retinal image registration approach combining area-based and feature-based methods
Number of subjects: 504
Study 14519797 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopheryl acetate (400 IU/d)
Number of subjects: 184
Study 14519797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 10740948 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma writing condition
Number of subjects: 98
Study 10740948 — intervention group
Group type: COMPARATOR
Intervention: Trivial writing control
Number of subjects: 98
Study 10740948 — intervention group
Group type: COMPARATOR
Intervention: No-writing control
Number of subjects: 98
Study 8912036 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier age of onset of bulimia
Number of subjects: 114
Study 8912036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower character scores (measured by the Temperament and Character Inventory)
Number of subjects: 114
Study 8912036 — intervention group
Group type: EXPERIMENTAL
Intervention: Worse mean parental care (from the Parental Bonding Instrument)
Number of subjects: 114
Study 8912036 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of any lifetime anxiety disorder
Number of subjects: 114
Study 8912036 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of any lifetime mood disorder
Number of subjects: 114
Study 1420749 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid Gaviscon
Number of subjects: 0
Study 1420749 — intervention group
Group type: EXPERIMENTAL
Intervention: Algicon Suspension
Number of subjects: 0
Study 1420749 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 0
Study 6319067 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg every 12 hr)
Number of subjects: 10
Study 29924506 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 181
Study 29924506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 26842950 — intervention group
Group type: EXPERIMENTAL
Intervention: anakinra-methotrexate
Number of subjects: 154
Study 26842950 — intervention group
Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 154
Study 25371639 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting during Ramadan
Number of subjects: 60
Study 21907450 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids (6000 mg/d in 3 divided doses)
Number of subjects: 20
Study 21907450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20827138 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 7
Study 18184542 — intervention group
Group type: EXPERIMENTAL
Intervention: Huannao Yicong capsule
Number of subjects: 90
Study 18184542 — intervention group
Group type: COMPARATOR
Intervention: Aniracetam
Number of subjects: 90
Study 11530030 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose inhaled fluticasone (88 microg twice daily)
Number of subjects: 294
Study 11530030 — intervention group
Group type: COMPARATOR
Intervention: Oral zafirlukast (20 mg twice daily)
Number of subjects: 294
Study 11530030 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching from zafirlukast to fluticasone (88 microg twice daily)
Number of subjects: 294
Study 9587723 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 120
Study 9587723 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 120
Study 9587723 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 120
Study 9587723 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 120
Study 7930305 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg three times daily)
Number of subjects: 12
Study 7930305 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg once daily)
Number of subjects: 12
Study 7930305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3371476 — intervention group
Group type: EXPERIMENTAL
Intervention: Nolvadex (tamoxifen)
Number of subjects: 87
Study 3371476 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 87
Study 31980978 — intervention group
Group type: EXPERIMENTAL
Intervention: Dotinurad 2 mg
Number of subjects: 201
Study 31980978 — intervention group
Group type: COMPARATOR
Intervention: Benzbromarone 50 mg
Number of subjects: 201
Study 30219400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol before primary PCI
Number of subjects: 197
Study 30219400 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 197
Study 28599338 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based intervention (phone calls every 4 weeks over 6 months)
Number of subjects: 172
Study 28599338 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 172
Study 25987198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for panic disorder
Number of subjects: 379
Study 25987198 — intervention group
Group type: COMPARATOR
Intervention: Higher aggression levels
Number of subjects: 379
Study 24390944 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole and NAC
Number of subjects: 90
Study 24390944 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole and placebo
Number of subjects: 90
Study 24390944 — intervention group
Group type: COMPARATOR
Intervention: NAC and placebo
Number of subjects: 90
Study 24390944 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 21486113 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term anticoagulation therapy with warfarin (OAC group)
Number of subjects: 31
Study 21486113 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anticoagulant or antiaggregant drugs)
Number of subjects: 31
Study 18647510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavities prepared with Er, Cr:YSGG laser (power settings varying for enamel=2.5 W and 3 W and dentine=1.0 W and 1.5 W) and restored with resin-modified glass ionomer cement (RMGIC) (Vitremer)
Number of subjects: 100
Study 18647510 — intervention group
Group type: COMPARATOR
Intervention: Cavities prepared with high-speed drill (HD) and restored with conventional glass ionomer cement (CGIC) (Ketac Molar Easy Mix)
Number of subjects: 100
Study 18647510 — intervention group
Group type: COMPARATOR
Intervention: Cavities prepared with Er, Cr:YSGG laser and restored with CGIC
Number of subjects: 100
Study 18647510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavities prepared with high-speed drill and restored with RMGIC
Number of subjects: 100
Study 17138219 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-lymph-node biopsy (SLNB) followed by ALND only if the SLN was involved (SLN group)
Number of subjects: 516
Study 17138219 — intervention group
Group type: COMPARATOR
Intervention: Sentinel-lymph-node biopsy (SLNB) and total axillary-lymph-node dissection (ALND group)
Number of subjects: 516
Study 17138219 — intervention group
Group type: COMPARATOR
Intervention: Overall survival in the ALND group
Number of subjects: 516
Study 17138219 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival in the SLN group
Number of subjects: 516
Study 12753370 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival irrigation with 10% PVP-iodine together with scaling and root planing
Number of subjects: 16
Study 12753370 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 16
Study 12753370 — intervention group
Group type: COMPARATOR
Intervention: Subgingival irrigation with 10% PVP-iodine
Number of subjects: 16
Study 12753370 — intervention group
Group type: COMPARATOR
Intervention: Subgingival irrigation with sterile saline
Number of subjects: 16
Study 11789221 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Salviae Dropping Pill (CSDP), 10 pills three times a day for 4 weeks
Number of subjects: 42
Study 11789221 — intervention group
Group type: COMPARATOR
Intervention: Control group (aspirin and other conservative agents only)
Number of subjects: 42
Study 9095007 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (2.5 mg) every 60 minutes for two doses, interspersed with saline aerosols every 20 minutes
Number of subjects: 86
Study 9095007 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (2.5 mg) every 20 minutes for 2 hours
Number of subjects: 86
Study 8459640 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegafur plus mitomycin C
Number of subjects: 169
Study 8459640 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT (uracil and tegafur in a 4:1 molar ratio) plus mitomycin C
Number of subjects: 169
Study 8459640 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary gastric lesion responded to chemotherapy
Number of subjects: 169
Study 8459640 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary gastric lesion did not respond to chemotherapy
Number of subjects: 169
Study 28880576 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based motivational intervention (IMI) supported by pedometers
Number of subjects: 76
Study 28880576 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based motivational intervention (IMI) alone
Number of subjects: 76
Study 28880576 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention
Number of subjects: 76
Study 28303753 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TAF
Number of subjects: 663
Study 28303753 — intervention group
Group type: COMPARATOR
Intervention: FTC/TAF (boosted PI)
Number of subjects: 663
Study 28303753 — intervention group
Group type: COMPARATOR
Intervention: FTC/TDF (boosted PI)
Number of subjects: 663
Study 28303753 — intervention group
Group type: COMPARATOR
Intervention: FTC/TAF (unboosted third agent)
Number of subjects: 663
Study 28303753 — intervention group
Group type: COMPARATOR
Intervention: FTC/TDF (unboosted third agent)
Number of subjects: 663
Study 25085943 — intervention group
Group type: EXPERIMENTAL
Intervention: SiPAP (bi-level nasal CPAP)
Number of subjects: 20
Study 25085943 — intervention group
Group type: COMPARATOR
Intervention: nCPAP (conventional nasal CPAP)
Number of subjects: 20
Study 22562974 — intervention group
Group type: EXPERIMENTAL
Intervention: MR prednisone 5 mg once daily in the evening plus DMARD
Number of subjects: 350
Study 22562974 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus DMARD
Number of subjects: 350
Study 21903909 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT) with tube voltages 80 and Sn140 kVp
Number of subjects: 64
Study 21903909 — intervention group
Group type: COMPARATOR
Intervention: Standard single-energy CT (SECT) at 120 kVp
Number of subjects: 64
Study 21903909 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT)
Number of subjects: 64
Study 21903909 — intervention group
Group type: COMPARATOR
Intervention: Standard single-energy CT (SECT)
Number of subjects: 64
Study 18422837 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP1, PIIINP, HA (adjusted for age)
Number of subjects: 247
Study 18422837 — intervention group
Group type: EXPERIMENTAL
Intervention: Various serum markers (TIMP1, tenascin, collagen VI, PIIINP, MMP2, laminin, HA)
Number of subjects: 247
Study 18422837 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers assessed every 3 months
Number of subjects: 247
Study 18422837 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating curves (ROC) analysis
Number of subjects: 247
Study 16972709 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12559133 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow endotracheal suctioning (ETS)
Number of subjects: 27
Study 12559133 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep endotracheal suctioning (ETS)
Number of subjects: 27
Study 10792143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff inflated
Number of subjects: 149
Study 10792143 — intervention group
Group type: COMPARATOR
Intervention: Cuff deflated
Number of subjects: 149
Study 9358137 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg of budesonide plus 12 microg of formoterol
Number of subjects: 852
Study 9358137 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg of budesonide plus 12 microg of formoterol
Number of subjects: 852
Study 9358137 — intervention group
Group type: COMPARATOR
Intervention: 100 microg of budesonide plus placebo
Number of subjects: 852
Study 9358137 — intervention group
Group type: COMPARATOR
Intervention: 400 microg of budesonide plus placebo
Number of subjects: 852
Study 8179543 — intervention group
Group type: COMPARATOR
Intervention: Surgicraft Copeland clip fetal scalp electrode (52 patients)
Number of subjects: 106
Study 8179543 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditrace spiral single helix scalp electrode (54 patients)
Number of subjects: 106
Study 3516752 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 500 mg
Number of subjects: 254
Study 3516752 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 500 mg
Number of subjects: 254
Study 3516752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 31331006 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of any of the ten individual fatty acids (genetic predisposition)
Number of subjects: 588190
Study 29923294 — intervention group
Group type: EXPERIMENTAL
Intervention: BioChaperone Lispro (BCLIS)
Number of subjects: 35
Study 29923294 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (LIS)
Number of subjects: 35
Study 26708298 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based health insurance (CBHI) schemes
Number of subjects: 0
Study 26708298 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 24731301 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (anterior discectomy or posterior foraminotomy)
Number of subjects: 400
Study 24731301 — intervention group
Group type: COMPARATOR
Intervention: Prolonged conservative care with surgery if needed
Number of subjects: 400
Study 24731301 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 400
Study 24731301 — intervention group
Group type: COMPARATOR
Intervention: Conservative care
Number of subjects: 400
Study 23038415 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% levobupivacaine with 5 μg/mL epinephrine
Number of subjects: 11
Study 23038415 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.25% levobupivacaine without epinephrine
Number of subjects: 11
Study 20400097 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 41
Study 20400097 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 41
Study 17700386 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone result disclosure
Number of subjects: 111
Study 17700386 — intervention group
Group type: COMPARATOR
Intervention: In-person result disclosure
Number of subjects: 111
Study 16005438 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrapone (cortisol synthesis inhibitor)
Number of subjects: 14
Study 16005438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 14564242 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium (1.3 mg/kg)
Number of subjects: 126
Study 14564242 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium (0.6 mg/kg)
Number of subjects: 126
Study 14564242 — intervention group
Group type: COMPARATOR
Intervention: Atracurium (0.5 mg/kg)
Number of subjects: 126
Study 14564242 — intervention group
Group type: COMPARATOR
Intervention: Cisatracurium (0.15 mg/kg)
Number of subjects: 126
Study 14564242 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium (0.1 mg/kg)
Number of subjects: 126
Study 10503666 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 0
Study 10503666 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous HA
Number of subjects: 0
Study 8661828 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 64
Study 8661828 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 64
Study 1832944 — intervention group
Group type: COMPARATOR
Intervention: TAM (20 mg b.i.d.)
Number of subjects: 20
Study 1832944 — intervention group
Group type: EXPERIMENTAL
Intervention: TAM-MPA (TAM 20 mg b.i.d. for 7 days, then TAM plus 500 mg MPA for 7 days)
Number of subjects: 20
Study 1832944 — intervention group
Group type: EXPERIMENTAL
Intervention: TAM-MPA
Number of subjects: 20
Study 1832944 — intervention group
Group type: COMPARATOR
Intervention: TAM
Number of subjects: 20